Cell therapies represent an exciting and complex new treatment paradigm, with the potential to treat an enormous range of indications, and in some cases offer the possibility of a cure with only a single treatment.
NYBC Enterprises shared our focus on our Integrated Lab Network, Specialty Laboratories, and groundbreaking Medicine and Science.
Follow our blog for the latest news and insights from our experts to stay at the forefront of the industry.
We are proud to congratulate Dr. Beth Shaz, Executive Vice President, Chief Medical and Scientific Officer of NYBC on being named one of Crain’s Notable Women in Healthcare.
CCS offers a comprehensive menu of products and services to develop, improve, and implement scientific studies in the areas of regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors.
Comprehensive Cell Solutions™ (CCS) leverages NYBC's strengths of innovation, flexibility, mobility, creativity, and quality.
At every step in the pipeline.
Stay at the forefront of the industry.
Don't see what you're looking for? Please ask!